Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives
Prostate cancer, a slow-growing tumor, develops through the over-proliferation of malignant cells in the prostate and is one of the most common types of cancer. Active surveillance, radical prostatectomy, external beam radiation, brachytherapy, cryotherapy, stereotactic body radiation therapy, hormo...
Saved in:
| Main Author: | Vikrant Rai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/6/751 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors
by: Hua Lu, et al.
Published: (2025-06-01) -
Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook
by: Wenhao Zhou, et al.
Published: (2024-12-01) -
Research progress of immune checkpoint inhibitors in ovarian cancer
by: Lingli Zhao, et al.
Published: (2024-12-01) -
Immune-checkpoint inhibitor resistance in patients with cancer
by: Luis Cabezón-Gutiérrez, et al.
Published: (2025-05-01) -
Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects
by: Can Lu, et al.
Published: (2025-06-01)